Year: 2020

…read more […]

(Bloomberg) — The parent company of TheStreet Inc., a financial news website co-founded by media personality Jim Cramer, received a $5.7 million loan as part of a program aimed at helping U.S. small businesses weather the pandemic.The loan was included in documents released by the federal government on Monday chronicling the $669 billion Paycheck Protection Program. A spokesman for TheMaven Inc., which acquired TheStreet in 2019 for $16.5 million, said that for “ease-of-process” reasons the borrowing was taken out under TheStreet’s name, but that it was for the entire consolidated company, which owns media properties such as Sports Illustrated.Cramer, who …read more […]

JPMorgan says a Biden win in November may be good for markets. Yahoo Finance’s Rick Newman joins The Final Round to discuss. …read more […]

Democrats and Republicans have voiced increasing antipathy over Section 230 — and it could mean costly political trouble for Facebook, YouTube and Twitter. …read more […]

…read more […]

…read more […]

The impact of COVID-19 is still being felt within markets. Sam Stovall, Chief Investment Strategist at CFRA joins The Final Round to break down what that might look like in Q2. …read more […]

I adhere to a remarkably simple rule in investing…
Revenue must be growing.
I’m not always a stickler for profits. Oftentimes, a young business is going to operate at a loss. But revenue growth shows there is demand for the product and that the company should eventually be profitable.
Revenue is the real engine behind fortune-minting moves.
And I believe share price will, in many cases, ultimately follow sales.
That’s why I’m always on the lookout for companies with eye-popping revenue growth.
I don’t care whether the mainstream media is covering the companies or not. I’m not bothered if few or no analysts are following them.
In …read more […]

Out on the Street, it’s full speed ahead. Despite the chaotic events of 2020, the S&P 500, which is coming off of its best quarter in more than 20 years, is down by only 2% year-to-date. Somewhat remarkably, the market has continued to charge forward as the number of new COVID-19 cases surges. As COVID-19 could be with us in waves for some time, there’s plenty of uncertainty going forward into the second half of the year. Consequently, spotting compelling plays can feel like a fool’s errand, especially given the hefty toll the virus has already taken on companies …read more […]

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also… …read more […]

(Bloomberg) — Remember when Tesla Inc.’s market value surpassed General Motors Co.? That was just in October, though investors can’t be blamed for thinking it was a lifetime ago.The electric vehicle maker’s valuation has added the combined value of the Big Three — GM, Ford Motor Co. and Fiat Chrysler — in just five trading days through Monday. Tesla has grown by an average $14 billion on each of those days.Tesla shares have been on a searing rally this year, recovering spectacularly from a steep pandemic-related sell-off, helped most recently by second-quarter delivery numbers that surpassed market estimates. In the …read more […]

JMP Securities increased its price target to $1,500 from $1,050 after Tesla last Thursday reported higher-than-expected second-quarter vehicle deliveries, defying a trend of plummeting sales in the wider auto industry as the coronavirus pandemic slammed the global economy. “We believe that the question to be considered is not whether the stock is expensive on current valuation measures, but what the company’s growth and competitive position signal about the stock’s potential for the next several years,” JMP Securities analyst Joseph Osha wrote in a client note, predicting that Tesla’s annual sales could hit $100 billion by 2025. JPMorgan, which …read more […]

With Biden surging ahead of President Trump in 2020 election polls, investors are beginning to worry that a Biden presidency could end the market-friendly policies Trump has propagated. Yahoo Finance’s Rick Newman and Kristin Myers discuss. …read more […]

And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim data from the early stage trial of its COVID-19 vaccine candidate, INO-4800.You could chalk the dip up to a classic case of “buy the rumor, sell the news,” but this sell-off was slightly more nuanced, with the lack of a clear good/bad story leaving a lot to interpretation.The company said that after giving participants two doses of the vaccine, 94% “demonstrated overall immune responses.” What probably concerned …read more […]

Wedbush Securities Chief Technology Strategist Brad Gastwirth joins Yahoo Finance’s Zack Guzman to discuss Elon Musk’s recent jab at Tesla short-sellers by listing “short shorts” on the company’s website. …read more […]